EMEA (Europe, Middle East and Africa) Opioids Market Report 2017

July 2017 | 103 pages | ID: E29C167B39FEN
QYResearch

Abstracts

In this report, the EMEA Opioids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Opioids for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Opioids market competition by top manufacturers/players, with Opioids sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer Inc
• Purdue Pharma
• Boehringer Ingelheim
• Janssen Pharmaceuticals
• Actavis Plc
• Sanofi
• Sun Pharmaceutical Industries Ltd
• Mallinckrodt Pharmaceuticals
• Endo Pharmaceuticals Inc
• Egalet

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Morphine
• Codeine
• Methadone
• Meperidine
• Fentanyl

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Opioids for each application, including

• Anesthesia
• Cough Suppressant
• Diarrhea suppressant

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Opioids Market Report 2017

1 OPIOIDS OVERVIEW

1.1 Product Overview and Scope of Opioids
1.2 Classification of Opioids
  1.2.1 EMEA Opioids Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Opioids Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Morphine
  1.2.4 Codeine
  1.2.5 Methadone
  1.2.6 Meperidine
  1.2.7 Fentanyl
1.3 EMEA Opioids Market by Application/End Users
  1.3.1 EMEA Opioids Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Anesthesia
  1.3.3 Cough Suppressant
  1.3.4 Diarrhea suppressant
1.4 EMEA Opioids Market by Region
  1.4.1 EMEA Opioids Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Opioids (2012-2022)
  1.5.1 EMEA Opioids Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Opioids Revenue and Growth Rate (2012-2022)

2 EMEA OPIOIDS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Opioids Market Competition by Players/Manufacturers
  2.1.1 EMEA Opioids Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Opioids Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Opioids Sale Price by Players (2012-2017)
2.2 EMEA Opioids (Volume and Value) by Type/Product Category
  2.2.1 EMEA Opioids Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Opioids Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Opioids Sale Price by Type (2012-2017)
2.3 EMEA Opioids (Volume) by Application
2.4 EMEA Opioids (Volume and Value) by Region
  2.4.1 EMEA Opioids Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Opioids Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Opioids Sales Price by Region (2012-2017)

3 EUROPE OPIOIDS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Opioids Sales and Value (2012-2017)
  3.1.1 Europe Opioids Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Opioids Revenue and Growth Rate (2012-2017)
3.2 Europe Opioids Sales and Market Share by Type
3.3 Europe Opioids Sales and Market Share by Application
3.4 Europe Opioids Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Opioids Sales Volume by Countries (2012-2017)
  3.4.2 Europe Opioids Revenue by Countries (2012-2017)
  3.4.3 Germany Opioids Sales and Growth Rate (2012-2017)
  3.4.4 France Opioids Sales and Growth Rate (2012-2017)
  3.4.5 UK Opioids Sales and Growth Rate (2012-2017)
  3.4.6 Russia Opioids Sales and Growth Rate (2012-2017)
  3.4.7 Italy Opioids Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Opioids Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OPIOIDS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Opioids Sales and Value (2012-2017)
  4.1.1 Middle East Opioids Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Opioids Revenue and Growth Rate (2012-2017)
4.2 Middle East Opioids Sales and Market Share by Type
4.3 Middle East Opioids Sales and Market Share by Application
4.4 Middle East Opioids Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Opioids Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Opioids Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Opioids Sales and Growth Rate (2012-2017)
  4.4.4 Israel Opioids Sales and Growth Rate (2012-2017)
  4.4.5 UAE Opioids Sales and Growth Rate (2012-2017)
  4.4.6 Iran Opioids Sales and Growth Rate (2012-2017)

5 AFRICA OPIOIDS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Opioids Sales and Value (2012-2017)
  5.1.1 Africa Opioids Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Opioids Revenue and Growth Rate (2012-2017)
5.2 Africa Opioids Sales and Market Share by Type
5.3 Africa Opioids Sales and Market Share by Application
5.4 Africa Opioids Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Opioids Sales Volume by Countries (2012-2017)
  5.4.2 Africa Opioids Revenue by Countries (2012-2017)
  5.4.3 South Africa Opioids Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Opioids Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Opioids Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Opioids Sales and Growth Rate (2012-2017)

6 EMEA OPIOIDS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioids Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Inc Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Purdue Pharma
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Opioids Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Opioids Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Janssen Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Opioids Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Janssen Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Actavis Plc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Opioids Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Actavis Plc Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Opioids Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sun Pharmaceutical Industries Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Opioids Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sun Pharmaceutical Industries Ltd Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mallinckrodt Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Opioids Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mallinckrodt Pharmaceuticals Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Endo Pharmaceuticals Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Opioids Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Endo Pharmaceuticals Inc Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Egalet
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Opioids Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Egalet Opioids Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 OPIOIDS MANUFACTURING COST ANALYSIS

7.1 Opioids Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioids

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioids Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioids Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OPIOIDS MARKET FORECAST (2017-2022)

11.1 EMEA Opioids Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Opioids Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Opioids Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Opioids Price and Trend Forecast (2017-2022)
11.2 EMEA Opioids Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Opioids Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Opioids Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Opioids Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Opioids Sales Forecast by Type (2017-2022)
11.7 EMEA Opioids Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Opioids
Figure EMEA Opioids Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Opioids Sales Volume Market Share by Type (Product Category) in 2016
Figure Morphine Product Picture
Figure Codeine Product Picture
Figure Methadone Product Picture
Figure Meperidine Product Picture
Figure Fentanyl Product Picture
Figure EMEA Opioids Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Opioids by Application in 2016
Figure Anesthesia Examples
Table Key Downstream Customer in Anesthesia
Figure Cough Suppressant Examples
Table Key Downstream Customer in Cough Suppressant
Figure Diarrhea suppressant Examples
Table Key Downstream Customer in Diarrhea suppressant
Figure EMEA Opioids Market Size (Million USD) by Region (2012-2022)
Figure Europe Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Opioids Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Opioids Revenue (Million USD) Status and Forecast by Countries
Figure Africa Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Opioids Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Opioids Sales Volume and Growth Rate (2012-2022)
Figure EMEA Opioids Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Opioids Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Opioids Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Opioids Sales Share by Players (2012-2017)
Figure 2016 Opioids Sales Share by Players
Figure 2017 Opioids Sales Share by Players
Figure EMEA Opioids Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Opioids Revenue (Million USD) by Players (2012-2017)
Table EMEA Opioids Revenue Share by Players (2012-2017)
Table 2016 EMEA Opioids Revenue Share by Players
Table 2017 EMEA Opioids Revenue Share by Players
Table EMEA Opioids Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Opioids Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Opioids Sales Share by Type (2012-2017)
Figure Sales Market Share of Opioids by Type (2012-2017)
Figure EMEA Opioids Sales Market Share by Type (2012-2017)
Table EMEA Opioids Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Opioids Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioids by Type in 2016
Table EMEA Opioids Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Opioids Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Opioids Sales Share by Application (2012-2017)
Figure Sales Market Share of Opioids by Application (2012-2017)
Figure EMEA Opioids Sales Market Share by Application in 2016
Table EMEA Opioids Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Opioids Sales Share by Region (2012-2017)
Figure Sales Market Share of Opioids by Region (2012-2017)
Figure EMEA Opioids Sales Market Share in 2016
Table EMEA Opioids Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Opioids Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Opioids by Region (2012-2017)
Figure EMEA Opioids Revenue Market Share Regions in 2016
Table EMEA Opioids Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Opioids Revenue and Growth Rate (2012-2017)
Table Europe Opioids Sales (K Units) by Type (2012-2017)
Table Europe Opioids Market Share by Type (2012-2017)
Figure Europe Opioids Market Share by Type in 2016
Table Europe Opioids Sales (K Units) by Application (2012-2017)
Table Europe Opioids Market Share by Application (2012-2017)
Figure Europe Opioids Market Share by Application in 2016
Table Europe Opioids Sales (K Units) by Countries (2012-2017)
Table Europe Opioids Sales Market Share by Countries (2012-2017)
Figure Europe Opioids Sales Market Share by Countries (2012-2017)
Figure Europe Opioids Sales Market Share by Countries in 2016
Table Europe Opioids Revenue (Million USD) by Countries (2012-2017)
Table Europe Opioids Revenue Market Share by Countries (2012-2017)
Figure Europe Opioids Revenue Market Share by Countries (2012-2017)
Figure Europe Opioids Revenue Market Share by Countries in 2016
Figure Germany Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure France Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure UK Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Opioids Sales (K Units) by Type (2012-2017)
Table Middle East Opioids Market Share by Type (2012-2017)
Figure Middle East Opioids Market Share by Type (2012-2017)
Table Middle East Opioids Sales (K Units) by Applications (2012-2017)
Table Middle East Opioids Market Share by Applications (2012-2017)
Figure Middle East Opioids Sales Market Share by Application in 2016
Table Middle East Opioids Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Opioids Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Opioids Sales Volume Market Share by Countries in 2016
Table Middle East Opioids Revenue (Million USD) by Countries (2012-2017)
Table Middle East Opioids Revenue Market Share by Countries (2012-2017)
Figure Middle East Opioids Revenue Market Share by Countries (2012-2017)
Figure Middle East Opioids Revenue Market Share by Countries in 2016
Figure Saudi Arabia Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Opioids Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Opioids Sales (K Units) by Type (2012-2017)
Table Africa Opioids Sales Market Share by Type (2012-2017)
Figure Africa Opioids Sales Market Share by Type (2012-2017)
Figure Africa Opioids Sales Market Share by Type in 2016
Table Africa Opioids Sales (K Units) by Application (2012-2017)
Table Africa Opioids Sales Market Share by Application (2012-2017)
Figure Africa Opioids Sales Market Share by Application (2012-2017)
Table Africa Opioids Sales Volume (K Units) by Countries (2012-2017)
Table Africa Opioids Sales Market Share by Countries (2012-2017)
Figure Africa Opioids Sales Market Share by Countries (2012-2017)
Figure Africa Opioids Sales Market Share by Countries in 2016
Table Africa Opioids Revenue (Million USD) by Countries (2012-2017)
Table Africa Opioids Revenue Market Share by Countries (2012-2017)
Figure Africa Opioids Revenue Market Share by Countries (2012-2017)
Figure Africa Opioids Revenue Market Share by Countries in 2016
Figure South Africa Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Opioids Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Inc Opioids Basic Information List
Table Pfizer Inc Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc Opioids Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Opioids Revenue Market Share in EMEA (2012-2017)
Table Purdue Pharma Opioids Basic Information List
Table Purdue Pharma Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Purdue Pharma Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Purdue Pharma Opioids Sales Market Share in EMEA (2012-2017)
Figure Purdue Pharma Opioids Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Opioids Basic Information List
Table Boehringer Ingelheim Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Opioids Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Opioids Revenue Market Share in EMEA (2012-2017)
Table Janssen Pharmaceuticals Opioids Basic Information List
Table Janssen Pharmaceuticals Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals Opioids Sales Market Share in EMEA (2012-2017)
Figure Janssen Pharmaceuticals Opioids Revenue Market Share in EMEA (2012-2017)
Table Actavis Plc Opioids Basic Information List
Table Actavis Plc Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Plc Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Actavis Plc Opioids Sales Market Share in EMEA (2012-2017)
Figure Actavis Plc Opioids Revenue Market Share in EMEA (2012-2017)
Table Sanofi Opioids Basic Information List
Table Sanofi Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Opioids Sales Market Share in EMEA (2012-2017)
Figure Sanofi Opioids Revenue Market Share in EMEA (2012-2017)
Table Sun Pharmaceutical Industries Ltd Opioids Basic Information List
Table Sun Pharmaceutical Industries Ltd Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Opioids Sales Market Share in EMEA (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Opioids Revenue Market Share in EMEA (2012-2017)
Table Mallinckrodt Pharmaceuticals Opioids Basic Information List
Table Mallinckrodt Pharmaceuticals Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mallinckrodt Pharmaceuticals Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Mallinckrodt Pharmaceuticals Opioids Sales Market Share in EMEA (2012-2017)
Figure Mallinckrodt Pharmaceuticals Opioids Revenue Market Share in EMEA (2012-2017)
Table Endo Pharmaceuticals Inc Opioids Basic Information List
Table Endo Pharmaceuticals Inc Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Endo Pharmaceuticals Inc Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Endo Pharmaceuticals Inc Opioids Sales Market Share in EMEA (2012-2017)
Figure Endo Pharmaceuticals Inc Opioids Revenue Market Share in EMEA (2012-2017)
Table Egalet Opioids Basic Information List
Table Egalet Opioids Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Egalet Opioids Sales (K Units) and Growth Rate (2012-2017)
Figure Egalet Opioids Sales Market Share in EMEA (2012-2017)
Figure Egalet Opioids Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids
Figure Manufacturing Process Analysis of Opioids
Figure Opioids Industrial Chain Analysis
Table Raw Materials Sources of Opioids Major Manufacturers in 2016
Table Major Buyers of Opioids
Table Distributors/Traders List
Figure EMEA Opioids Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Opioids Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Opioids Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Opioids Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Opioids Sales Market Share Forecast by Region (2017-2022)
Table EMEA Opioids Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Opioids Revenue Market Share Forecast by Region (2017-2022)
Table Europe Opioids Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Opioids Sales Market Share Forecast by Countries (2017-2022)
Table Europe Opioids Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Opioids Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Opioids Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Opioids Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Opioids Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Opioids Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Opioids Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Opioids Sales Market Share Forecast by Countries (2017-2022)
Table Africa Opioids Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Opioids Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Opioids Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Opioids Sales Market Share Forecast by Type (2017-2022)
Table EMEA Opioids Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Opioids Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources